DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Mangalam Global Enterprise Limited — Board Meeting Intimation

NSE 41 min ago·28 Jul 2026, 10:31 am

Mangalam Drug & Chem

Mangalam Global Enterprise Limited has announced that its board will meet on August 1, 2026, to review and approve the company's unaudited financial results for the quarter ending June 2026. This is a standard corporate procedure where the board reviews the company's performance before the results are officially released to the public.

For investors, this update is significant as it provides a preview of the company's operational health and financial performance during the first half of the financial year. The results will reveal whether the company met its targets and offer insights into its future growth trajectory.

Investors should watch for the actual release of these results to gauge the company's performance and management's commentary on future prospects.